Back to search
FDAFDA · Food and drugs·Recall number D-0157-2021

Best Choice, Clotrimazole Cream, USP 1%, Antifungal, NET WT 0.5 OZ (14.2g), Distributed by: Valu Merchandisers, CO . 5000 Kansas Ave. Kansas City, KS 66106 Made in Canada. UPC 0-70038-20355-1

Published December 23, 2020 · Recall initiated: November 17, 2020

Summary

FDA records drug Class II recall D-0157-2021, published December 23, 2020 and initiated November 17, 2020. Recalling firm: Taro Pharmaceuticals U.S.A., Inc.; Status: Terminated; Reported quantity: 11,088 1 oz tubes; Lot: Lot #: D867331087, Exp Mar, 2021 70,200 63,252. Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.

Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.

What's the hazard

Failed Impurities/Degradation Specifications: An unknown degradation impurity was detected slightly above the specification limit in Clotrimazole Cream USP 1%.

What to do

Voluntary: Firm initiated · Letter

Get an email when a new FDA recall like this is published

Free. We only write when there's a new recall that matches. Unsubscribe in one click.

Recall details

Manufacturer
Taro Pharmaceuticals U.S.A., Inc.
Distributor
Distributed Nationwide in the USA and Canada
Lot
Lot #: D867331087, Exp Mar, 2021 70,200 63,252
Risk classification
Class II
Area (FDA)
drug
Country
United States

Related recalls

Questions about this recall

Was Best Choice, Clotrimazole Cream, USP 1%, Antifungal, NET WT 0.5 OZ (14.2g), Distributed by: Valu Merchandisers, CO . 5000 Kansas Ave. Kansas City, KS 66106 Made in Canada. UPC 0-70038-20355-1 recalled?

Yes. FDA published recall D-0157-2021 on December 23, 2020. Reported hazard: Failed Impurities/Degradation Specifications: An unknown degradation impurity was detected slightly above the specification limit in Clotrimazole Cream USP 1%.

What should I do if I have this product?

Voluntary: Firm initiated · Letter